Metabolic (dysfunction)-associated fatty liver disease (MAFLD) affects up to a third of the
global population; its burden has grown in parallel with rising rates of type 2 diabetes …

The prevalence of obesity has consistently increased worldwide, and many obesity-related
diseases are emerging as major health problems. Body mass index (BMI) is used to define …

Background The influence of overall lifestyle behaviors on diabetic microvascular
complications remains unknown. In addition, the potential mediating biomarkers underlying …

The goal of the 8th edition of the Clinical Practice Guidelines for Obesity is to help primary
care physician provide safe, effective care to patients with obesity by offering evidence …

Background: Whether consumption of sugar-sweetened beverages (SSBs) or artificially
sweetened beverages (ASBs) is associated with risk of mortality is of public health interest …

Background Despite common mechanisms of actions, glucagon-like peptide-1 receptor
agonists differ in structure, pharmacokinetic profile, and clinical effects. This head-to-head …

Objective Development of these guidelines is mandated by the American Association of
Clinical Endocrinologists (AACE) Board of Directors and the American College of …

Objectives. To review the contribution of the Nurses' Health Studies (NHS and NHS II) in
addressing hypotheses regarding risk factors for and consequences of obesity. Methods …

There is a common perception that excess adiposity, commonly approximated by body mass
index (BMI), is associated with reduced cancer survival. A number of studies have emerged …

Importance The association between an overall healthy lifestyle and the subsequent risk of
microvascular complications among patients with diabetes remains unclear. Objective To …